Share on StockTwits

U.S. Physical Therapy (NASDAQ:USPH) Director Mark J. Brookner sold 549 shares of the stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $35.82, for a total transaction of $19,665.18. Following the completion of the sale, the director now directly owns 50,000 shares of the company’s stock, valued at approximately $1,791,000. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

U.S. Physical Therapy (NASDAQ:USPH) traded down 1.94% during mid-day trading on Wednesday, hitting $34.94. The stock had a trading volume of 22,308 shares. U.S. Physical Therapy has a 1-year low of $27.80 and a 1-year high of $37.25. The stock’s 50-day moving average is $35.3 and its 200-day moving average is $33.3. The company has a market cap of $427.5 million and a price-to-earnings ratio of 32.04.

U.S. Physical Therapy (NASDAQ:USPH) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.44 by $0.08. The company had revenue of $66.90 million for the quarter, compared to the consensus estimate of $74.25 million. During the same quarter in the previous year, the company posted $0.42 earnings per share. The company’s revenue for the quarter was up 16.9% on a year-over-year basis. Analysts expect that U.S. Physical Therapy will post $1.70 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Friday, September 5th. Stockholders of record on Monday, August 18th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 1.37%. The ex-dividend date of this dividend is Thursday, August 14th.

Separately, analysts at Jefferies Group raised their price target on shares of U.S. Physical Therapy from $38.00 to $40.00 in a research note on Friday, August 8th. Two equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $36.80.

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical and occupational therapy clinics that provide pre- and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Receive News & Ratings for US Physical Therapy Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for US Physical Therapy Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.